News
FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019
- Details

Themis raises EUR 40 Million in Series D financing round backed by US/EU consortium
- Details

Adrenomed Supervisory Board appoints Jens Schneider-Mergener as CEO & Jens Zimmermann (CMO) joins the Executive Board
- Details